MEGAN HARRIS: Open Payments
NPI 1164891990 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,381 in 129 payments from 17 companies in 2025. Trend: 2023 $1,151 · 2024 $2,832 · 2025 $2,381
Food & beverage: $2,201Education: $180
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $425 |
| UCB, Inc. | 18 | $403 |
| Janssen Biotech, Inc. | 17 | $319 |
| Galderma Laboratories, L.P. | 10 | $211 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $210 |
| Incyte Corporation | 12 | $189 |
| Novartis Pharmaceuticals Corporation | 7 | $127 |
| Lilly USA, LLC | 7 | $117 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| LEO Pharma Inc. | 3 | $64 |
Products named: Bimzelx, TREMFYA, RINVOQ, NEMLUVIO, OPZELURA, SKYRIZI, DUPIXENT, BLU-U.
Industry payments across AL — which companies pay providers there.
